Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Closes Acquisition of Dx QC Shop Blackhawk Biosystems

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it has closed its acquisition of Blackhawk Biosystems, a privately held maker of quality-control products for infectious disease testing.
Bio-Rad CEO Norman Schwartz said he expects this acquisition will help his company expand its online quality control and inter-laboratory peer group comparison.
Financial terms of the acquisition were not disclosed.
In the past year Bio-Rad also purchased ProteOptics and made an agreement to acquire Ciphergen’s proteomic tools business, including the company’s SELDI platform.
For more on Bio-Rad’s corporate strategy, including its acquisition outlook, read this interview with Bio-Rad vice president Brad Crutchfield conducted by GenomeWeb News sister publication ProteoMonitor

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.